Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Intal 5mg/dose inhaler
0303010Q0BBAFAB
|
Intal | Sodium cromoglicate | Respiratory System | No data available |
|
Intal 5mg/dose Syncroner with spacer
0303010Q0BBAKAJ
|
Intal | Sodium cromoglicate | Respiratory System | No data available |
|
Ipecacuanha 20mg tablets
0309020T0AAAFAF
|
Ipecacuanha | Ipecacuanha | Respiratory System | No data available |
|
Ipecacuanha alkaline mixture
0309020T0AAAAAA
|
Ipecacuanha | Ipecacuanha | Respiratory System | No data available |
|
Ipecacuanha and Ammonia mixture paediatric
0309020T0AAACAC
|
Ipecacuanha | Ipecacuanha | Respiratory System | No data available |
|
Ipecacuanha and Morphine mixture BP 1980
0309020T0AAAHAH
|
Ipecacuanha | Ipecacuanha | Respiratory System | No data available |
|
Ipecacuanha mixture paediatric
0309020T0AAABAB
|
Ipecacuanha | Ipecacuanha | Respiratory System | No data available |
|
Ipecacuanha opiate mixture paediatric
0309020T0AAADAD
|
Ipecacuanha | Ipecacuanha | Respiratory System | No data available |
|
Ipratropium 500micrograms/2ml neb liq ud Steripoule vials
0301020I0BHABAC
|
Ipratropium Steripoule | Ipratropium bromide | Respiratory System | No data available |
|
Ipratropium bromide 20micrograms/dose BA inhaler
0301020I0AAAGAG
|
Ipratropium bromide (Bronchodilators) | Ipratropium bromide | Respiratory System | No data available |
|
Ipratropium bromide 20micrograms/dose inhaler
0301020I0AAAAAA
|
Ipratropium bromide (Bronchodilators) | Ipratropium bromide | Respiratory System | No data available |
|
Ipratropium bromide 40microgram inhalation pdr caps with dev
0301020I0AAAHAH
|
Ipratropium bromide (Bronchodilators) | Ipratropium bromide | Respiratory System | No data available |
|
Ipratropium bromide 40microgram inhalation powder capsules
0301020I0AAAIAI
|
Ipratropium bromide (Bronchodilators) | Ipratropium bromide | Respiratory System | No data available |
|
Ipratropium bromide 40micrograms/dose inhaler
0301020I0AAADAD
|
Ipratropium bromide (Bronchodilators) | Ipratropium bromide | Respiratory System | No data available |
|
Ivacaftor 25mg granules sachets sugar free
0307000S0AAADAD
|
Ivacaftor | Ivacaftor | Respiratory System | No data available |
|
Ivacaftor 50mg granules sachets sugar free
0307000S0AAABAB
|
Ivacaftor | Ivacaftor | Respiratory System | No data available |
|
Ivacaftor 75mg granules sachets sugar free
0307000S0AAACAC
|
Ivacaftor | Ivacaftor | Respiratory System | No data available |
|
Jackson's Extra Strength All Fours 100mg/5ml oral solution
0309020G0BMAAAB
|
Jackson's All Fours (Guaifenesin) | Guaifenesin | Respiratory System | No data available |
|
Jackson's Lemon linctus
0309020H0BIAAAE
|
Jackson's Glycerol, Lemon and Honey | Glycerol | Respiratory System | No data available |
|
Jackson's The Original All Fours 50mg/5ml oral solution
0309020G0BMABAL
|
Jackson's All Fours (Guaifenesin) | Guaifenesin | Respiratory System | No data available |
|
Jackson's Vapour Rub
030800000BDBRA0
|
Proprietary compound preparation BNF 0308000 | Other aromatic inhalation preparations | Respiratory System | No data available |
|
Junior Meltus Chesty Coughs with Catarrh oral solution
0309020G0BJABAH
|
Meltus (Expectorant/Demulcents) | Guaifenesin | Respiratory System | No data available |
|
Junior Meltus Colour and Sugar Free Expectorant soln
0309020G0BJAAAH
|
Meltus (Expectorant/Demulcents) | Guaifenesin | Respiratory System | No data available |
|
Junior Meltus Dry Coughs with Congestion oral solution
030902000BECNA0
|
Proprietary compound preparation BNF 0309020 | Other expectorantand demulcent cough preparations | Respiratory System | No data available |
|
Kalydeco 25mg granules sachets
0307000S0BBADAD
|
Kalydeco | Ivacaftor | Respiratory System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.